This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on April 18, 2025.

Return to the list of Patented Medicine Litigation page.

---

---

Clopidogrel

PLAVIX – Sanofi-aventis Canada Inc. (NOC Search)

Patents:

• 1194875: APOTEX, PHARMASCIENCE, COBALT
• 1336777: APOTEX, MYLAN, PHARMASCIENCE, RANBAXY, DOMINION, PHARMASCIENCE, SIGNA, SIGNA, APOTEX, , ACTAVIS, SANDOZ, RIVA, TEVA, COBALT, NOVOPHARM
• 2334870: APOTEX, PHARMASCIENCE, COBALT

Unknown/Other

• Infringement – T-2008-13

ACTAVIS

• Infringement – T-2005-13

APOTEX

• Infringement – T-2000-13 – T-2002-13 – T-644-09 (2010 FC 1022, 2010 FC 1282, 2010 FC 182, 2010 FC 481, 2010 FC 77, 2011 FC 1486, 2011 FC 52, 2012 FC 318)
• Appeal – A-121-12 (2013 FCA 187) – A-168-05 (2006 FCA 421) – A-414-10
• PM(NOC) – T-1065-05 – T-668-03

COBALT

• PM(NOC) – T-1604-05

DOMINION, PHARMASCIENCE

• Infringement – T-2009-13

MYLAN

• Infringement – T-2006-13

NOVOPHARM

• PM(NOC) – T-64-05

PHARMASCIENCE

• PM(NOC) – T-1732-08

RANBAXY

• Infringement – T-2010-13

RIVA

• Infringement – T-2003-13

SANDOZ

• Infringement – T-2004-13

SIGNA

• Infringement – T-79-11

SIGNA, APOTEX

• Infringement – T-933-09
• Appeal – A-7-12 (2013 FCA 186, 2013 FCA 209)

TEVA

• Infringement – T-2007-13

---

Return to the Patented Medicine Litigation page.